Book publications
● Giannis G. Baltogiannis, Dimitrios N. Lysitsas et al. Sudden Cardiac Death
and Channelopathies. Lausanne: Frontiers Media SA. Doi:
10.3389/978-2-88966-370-5, CPVT: Arrhythmogenesis, Therapeutic
Management, and Future Perspectives. A Brief Review of the Literature
Publications in peer-reviewed journals
1. Vassilikos VP, Lysitsas D, Trends in ablation procedures in Greece over the
2008-2018 period: Results from the Hellenic Cardiology Society Ablation
Registry. Hellenic J Cardiol. 2020 Sep 19:S1109-9666(20)30195-0. doi:
10.1016/j.hjc.2020.09.005. Epub ahead of print. PMID: 32956809.
2. Baltogiannis GG, Lysitsas DN, et al. CPVT: Arrhythmogenesis, Therapeutic
Management, and Future Perspectives. A Brief Review of the Literature.
Front Cardiovasc Med. 2019 Jul 12;6:92
3. Tachmatzidis D, Filos d, Lysitsas DN et al. Alterations in atrial excitation
patterns revealed by wavelet analysis a year after successful ablation for
paroxysmal atrial fibrillation. European Heart Journal, Volume 39, Issue
suppl_1, August 2018, ehy565.P2881
4. Harris P, Lysitsas D. Ventricular arrhythmias and sudden death. BJA
Education, Volume 16, Issue 7, July 2016, Pages 221–229,
5. Wang J, Malhotra A, Bajwa F, Lysitsas DN. Don't know much about
embryology. CJEM 2015;16: 1-3
6. Sioros L, Baltogiannis JG, Lysitsas DN, Kolettis TM Treatment of
Catecholaminergic Polymorphic Ventricular Tachycardia: Lessons From One
Case. Hospital Chronicles. 2014; 9: 27–32
7. Bourantas CV, Papafaklis MI, Naka KK, Tsakanikas VD, Lysitsas DN,
Alamgir FM, Fotiadis DI, Michalis LK. Fusion of optical coherence
tomography and coronary angiography - in vivo assessment of shear stress in
plaque rupture. Int J Cardiol. 2012 March 8;155(2): e24-26
8. Lysitsas DN, Hussain W. Dabigatran: the end of warfarin. Cardiology
International. 2011; 2: 5-6
9. Moulas A, Papakostas J, Eglezopoulos K, Papamichael N, Lysitsas D,
Michalis L. Use of retinoic acid-eluting stents for preventing restenosis in an
animal model. Cardiovascular Revascularisation Medicine.
2010;11:276-277
10. Kolettis TM, Lysitsas DN et al. Improved ‘cut-down’ technique for
transvenous pacemaker lead implantation. Europace. 2010;12:1282-85
11. Lysitsas DN et al. Loop recorder implantation at the left axillary area.
Europace. 2010;12:603
12. Lysitsas DN et al. Cardiac tamponade due to left atrium direct invasion by a
large cell neuroendocrine metastatic carcinoma of the lung. Eur J
Echocardiogr. 2008 May;9(3):428-9.
13. Lysitsas DN et al. Presentation of an embolised Amplatzer septal occluder to
the main pulmonary artery 2 years after implantation. Int J Cardiol. 2009 Jan
24;131(3):e106-7
14. Lysitsas DN et al. "Antirestenotic effects of a novel polymer-coated D-24851
eluting stent. Experimental data in a rabbit iliac artery model." Cardiovasc
Intervent Radiol. 2007 Nov-Dec;30(6):1192-200
Poster presentations in International meetings
1. Tachmatzidis D, Lysitsas DN et al. Alterations in atrial excitation patterns
after successful ablation for paroxysmal atrial fibrillation. ESC Congress
2016
2. L.J.. Jarrett- Smith, C.B. Butcher, D.L. Lysitsas et al. Does time for diagnosis
of atrial fibrillation ablation affect success of catheter ablation, HRC
Congress 2015
3. Rochon M, Margerison N, Dimitrios Lysitsas, et al. Collaborative Working:
Surveillance of Wound Infections in Implant Devices (pacemakers, loop
systems and internal cardiac defibrillators). International Forum on Quality
and Safety in Health Care 17-20 April, Paris
4. Jarman J, Lysitsas DN et al. Determinants of Recurrence Following Persistent
Atrial Fibrillation Ablation. Cardiostim 2012
5. Jarman J, Lysitsas DN et al Additional Linear Lesions Following
Circumferential Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation
Do Not Predict Procedural Success. Cardiostim 2012
6. Jarman J, Lysitsas DN et al. A Simple and Effective Score to Predict the
Outcome of Persistent AF Ablation. HRS 2012
7. Jarman J, Lysitsas DN et al. Linear ablation at the left atrial roof and
outcomes of paroxysmal atrial fibrillation. ECAS 2012
8. Lysitsas et al. Antirestenotic effects of a novel polymer-coated D-24851
eluting stent. Experimental data in a rabbit iliac artery model." Hellenic
Cardiology Congress 2004
Invited Speaker in Cardiology Meetings
1. 19/12/2020 ICE 2020, Heraklion, Greece
How to treat a 70 year old patient with mild hypertension and history of
stroke, that presents symptomatic paroxysmal atrial fibrillation
2. 24/10/2020 HCS 2020, Athens, Greece
How should I monitor my patient post atrial fibrillation ablation
3. 18/09/2020 Pfizer Satellite symposium, Thessaloniki, Greece
Apixaban: Latest real world data
4. 07/03/2020 Pfizer Satellite symposium, Thessaloniki, Greece
Apixaban: Latest real world data
5. 21/02/2020 HCS Working Groups, Thessaloniki, Greece
Review : What have we learned from the most important published
medical studies.
6. 30/11/19, ICE 2019, Heraklion, Greece
Ablation of arrhythmias in adult congenital heart disease
7. 22/11/19, Hellenic College of Cardiology, Metsovo, Greece
Atrial fibrillation ablation in pathological substrate
8. 18/10/2019, HCS 2019, Ioannina, Greece
Ablation of atrial fibrillation- update
9. 12th Congress of Interventional Cardiology and Electrophysiology,
Thessaloniki, Greece
Lecture: Atrial fibrillation after treatment with ablation
10. 20/10/18, HCS Congress 2018, Athens, Greece
Debate: Left atrial appendage closure in the era of NOACs- in favor
11. 14/10/18, 11th Congress of Interventional Cardiology and Electrophysiology
Anticoagulation after ablation of atrial fibrillation
12. 17/02/17, HCS Working Groups, Thessaloniki, Greece
Apixaban: specific groups and real world data
13. 20/11/16, Case presentation and decision making, Ioannina, Greece
Case report in Electrophysiology
14. 19/11/16, Case presentation and decision making, Ioannina, Greece
Randomised clinical trials and data of routine clinical practise for NOACs
15. 22/10/16, HCS Congress 2016, Athens , Greece
Risk stratification of sudden cardiac death post myocardial infarction
16. 01/10/16, Hellenic Rhythmology Society, Athens, Greece
Percutaneous closure of left atrial appendage equivalent to anticoagulants
in prevention of stroke in patients with atrial fibrillation
17. 09/09/2016, 9th Congress of Interventional Cardiology and Electrophysiology
Technique of percutaneous left atrial appendage closure
18. 08/04/2016 Arrhythmias Update 2016, Greece
Debate : Current arrythmological subjects
19. 20/10/15, HCS 2015, Thessaloniki, Greece
Supraventricular tachycardia: Step by step differential diagnosis of
challenging cases
20. 29/04/2015- Arrhythmias Update 2015, Thessaloniki Greece
Percutaneous closure of left atrial appendage
21. 27/03/15- Hippokrates days of Cardiology, Thessaloniki, Greece
WPW syndrome: Diagnostic process and management
22. 14/03/15- Master Course of Imaging – 2015, Thessaloniki, Greece
Atrial Fibrillation-Catheter ablation
23. 27/02/15-HCS Working Groups, Ioannina, Greece
Frequent ventricular ectopics
24. 23/10/14- 35o Hellenic Cardiology Society, Athens, Greece
Thromboembolic events despite optimal anticoagulation therapy with
warfarin: what next
25. 12/04/14-14o "NEW TRENDS IN CARDIOLOGY", Thessaloniki, Greece
Interventional therapy of atrial fibrillation
26. 05/04/14- Master Course of Imaging, Thessaloniki, Greece
3D echocardiography and atrial fibrillation
27. 09/10/14- 7th Congress of Interventional Cardiology and Electrophysiology
Percutaneous closure of left atrial appendage- cases presentation
28. 11/10/14-7th Congress of Interventional Cardiology and Electrophysiology
Atrial fibrillation in young patients and athletes- clinical decision and
management
29. 16/11/13-6o Congress of Interventional Cardiology and Electrophysiology
Asymptomatic WPW: When EPS is necessary
30. 10/10/13- 34o Hellenic cardiology Society Congress, Athens, Greece
Novel technology in the ablation of atrial fibrillation
Invited Chairman in Cardiology Meetings
31. 09/04/2016 - Arrhythmias update 2016, Thessaloniki Greece
Recent developments in atrial fibrillation
.svg){kind=small}
.svg){kind=small}
.jpg)
